Regeneron Ventures - aVenture Asset Manager Research
Regeneron Ventures
Operating Status: Operating
Corporate venture capital arm of Regeneron Pharmaceuticals investing in biotechnology, healthcare, and health technology companies.
Location
Greenwich, CT, US
Regeneron Ventures is the corporate venture capital arm of Regeneron Pharmaceuticals, launched in 2024 with a $500 million commitment to invest in biotechnology, healthcare, and health technology companies. The fund focuses on building and growing early-stage companies across biopharmaceuticals, life sciences devices, and tools.
Based in Greenwich, Connecticut, Regeneron Ventures partners with founders and teams developing promising therapeutic and technology platforms, leveraging Regeneron's scientific and operational expertise to support portfolio company growth.
Regeneron Ventures - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies3
Current Portfolio Count3
Top Investment Stages
Series A1 (33.3%)
Series B1 (33.3%)
Series C1 (33.3%)
Stage Mix
Series A 33%Series B 33%Series C 33%
Concentration shown as share of disclosed investments by stage.
